A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...
Like other developing countries, Indonesia is facing a familiar dilemma: how to feed a growing population while protecting ...
The vast majority of consumers are open to purchasing gene-edited pork, according to new research from Circana, commissioned ...
As CRISPR moves from lab success to real-world medicine, 2026 will test whether these revolutionary gene-editing therapies ...
LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology ...
While PRRS-resistant pigs are not yet for sale in the U.S., research like Circana’s and CFI and FMI’s helps to illustrate ...
Three start-ups are aiming to create gene-edited babies. Columnist Michael Le Page has no doubt that editing our offspring ...
For a technology that costs millions, a collaborative approach may improve efficiency and allow the science to live up to its ...
A 10-month-old baby who sparked nationwide headlines after receiving a first-of-its kind gene-editing treatment was released from the hospital this week.
8don MSNOpinion
Cathie Wood invests heavily in gene-editing companies, offloads $30 million worth Tesla stock
Cathie Wood’s Ark Invest increased exposure to gene-editing names and autonomous mobility companies while further cutting ...
On the final trading day of 2025, Cathie Wood put an eye-brow raising $1.33 million to work in Intellia Therapeutics ( NTLA ) ...
The cell and gene therapy market is at a pivotal point, with a surge in approvals and a maturing pipeline. While oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback